Medicines with active substance bevacizumab — L — Antineoplastic and immunomodulating agents (8)
- ALYMSYSbevacizumabRxConcentrate for solution for infusion, 25mg/mlGH Genhelix S.A., Spain
- ALYMSYSbevacizumabRxConcentrate for solution for infusion, 400mg/16mlGH Genhelix S.A., Spain
- AVASTINbevacizumabRxConcentrate for solution for infusion, 25mg/mlF. Hoffmann-La Roche AG, Switzerland
- AVASTINbevacizumabRxConcentrate for solution for infusion, 25mg/mlF. Hoffmann-La Roche AG, Switzerland
- OYAVASbevacizumabRxConcentrate for solution for infusion, 25mg/mlGH Genhelix S.A., Spain
- OYAVASbevacizumabRxConcentrate for solution for infusion, 25mg/mlGH Genhelix S.A., Spain
- ZirabevbevacizumabRxConcentrate for solution for infusion, 25mg/mlPfizer Service Company BV, Belgium
- ZirabevbevacizumabRxConcentrate for solution for infusion, 25mg/mlPfizer Service Company BV, Belgium